The Boston-based startup’s Kula-N can produce nutrients “only when the plant needs,” by applying “energized” bacteria that fix both nitrogen and carbon in the soil.
The Cambridge, Massachusetts-based startup combines active ingredients, a 3D-printed delivery system, and motor-function tech to combat pests and disease in orchards.
Grondwork BioAg has developed a line of biobased inputs sold on five continents based on mychorrizae, which it describes as queen of biologicals.
FBN is offering the prebiotics, probiotics, photosynthetic enhancers, carbon sources, and advanced micronutrients through its FBN Direct portal.
The Danish startup aspires to become the leading supplier of concentrated pheromones as an active ingredient to companies formulating spray-on inputs for row crops.
Indigo, which raised $560 million last year, said the layoffs align with its new CEO’s goal “to direct resources to [its] four primary offerings” and “realize their value.”
The duo will commercialize the US startup’s “green chemistry” product that helps plants use fertilizer more efficiently through microbes.
Ghent’s Aphea Bio – which offers a novel, algorithm-driven approach to biological crop protection – just raised $16.6 million in a Series B round led by Astanor Ventures.
The Costa Rican startup tells AFN about its experience of raising capital in its home country.
The Emeryville, California startup has been developing biological analytics of soil DNA data to offer farmers crop protection insights and forecasts.
FBN’s recently unveiled Biological On-Farm R&D Network will connect developers of biological ag inputs directly with farmers to perform trials in full-scale testing environments.
Italy’s Valagro produces biostimulants and specialty nutrients for farming, as well as specialty ingredients for use in food, cosmetics, and animal feed.
The Ontario-based startup is counting on nanotechnology to offer farmers the benefits of both traditional chemical-based inputs and newer biological products.
Sponsored
Sponsored post: The innovator’s dilemma: why agbioscience innovation must focus on the farmer first